Fig. 1: Schematic of BP vaccine production and composition.

An endotoxin-free production strain of E. coli, ClearColi BL21(DE3), was bioengineered to produce P. falciparum CSP epitope-coated BPs in one step. Immunogenicity of epitope-coated BPs was analysed in the sheep model.